JACQUELINE REID: Open Payments
NPI 1033798756 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 41 payments from 16 companies in 2025. Trend: 2023 $1,102 · 2024 $1,085 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $201 |
| Chiesi USA, Inc. | 1 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $128 |
| Verona Pharma, Inc. | 4 | $84 |
| Grifols USA, LLC | 4 | $73 |
| Amgen Inc. | 3 | $71 |
| Mallinckrodt Hospital Products Inc. | 2 | $62 |
| GENZYME CORPORATION | 2 | $38 |
| HARMONY BIOSCIENCES LLC | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: NUCALA, OFEV, Ohtuvayre, DUPIXENT, Prolastin-C Liquid, TEZSPIRE, ACTHAR, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
